News

Encysive received another approvable letter for Thelin (sitaxsentan sodium), which is under review for the treatment of pulmonary arterial hypertension (PAH), in March. Investors had hoped that, this

Elaprase (idursulfase) is the first and only treatment approved for people suffering from Hunter syndrome, a rare, life-threatening genetic condition also known as mucopolysaccharidosis II. The product, which

After having successfully completed phase II clinical trials, Altus had previously planned to initiate phase III trials for both ALTU-135 and ALTU-238 in the second half of this

Antara (fenofibrate) is indicated as an adjunct treatment for hypercholesterolemia and hypertriglyceridemia in combination with diet. Clinical studies have shown that Antara along with a healthy diet is

Under the agreement, Schering-Plough Research Institute (SPRI), the R&D arm of Schering-Plough, will provide both scientific guidance and funding as Hurel continues its one-year R&D program aimed at

Diabetes is a major risk factor for cardiovascular death in transplant patients. The study results suggest that immunosuppressant efficacy is not the only factor to affect the long-term

AC-100 is a novel synthetic peptide derived from an endogenous human protein produced by bone and dental cells. The peptide demonstrated a favorable safety profile in the trial

VGV-1 is a suspension of thymus nuclear protein given through intramuscular injection. Results indicate statistically significant reductions in viral load in some patients, only mild adverse events attributed

PerkinElmer’s collaboration with the Johns Hopkins University and the University of Birmingham is expected to expand cancer research capabilities by giving key opinion leaders advanced tools, technology and